| The MR-Base platform supports systematic causal inference across the human phenome G Hemani, J Zheng, B Elsworth, KH Wade, V Haberland, D Baird, ... elife 7, e34408, 2018 | 4237 | 2018 |
| Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement VW Skrivankova, RC Richmond, BAR Woolf, J Yarmolinsky, NM Davies, ... Jama 326 (16), 1614-1621, 2021 | 980 | 2021 |
| Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases J Zheng, V Haberland, D Baird, V Walker, PC Haycock, MR Hurle, ... Nature genetics 52 (10), 1122-1131, 2020 | 355 | 2020 |
| Causal inference in cancer epidemiology: what is the role of Mendelian randomization? J Yarmolinsky, KH Wade, RC Richmond, RJ Langdon, CJ Bull, KM Tilling, ... Cancer Epidemiology, Biomarkers & Prevention 27 (9), 995-1010, 2018 | 127 | 2018 |
| Circulating selenium and prostate cancer risk: a Mendelian randomization analysis J Yarmolinsky, C Bonilla, PC Haycock, RJQ Langdon, LA Lotta, ... JNCI: Journal of the National Cancer Institute 110 (9), 1035-1038, 2018 | 108 | 2018 |
| STROBE-MR: guidelines for strengthening the reporting of Mendelian randomization studies GD Smith, NM Davies, N Dimou, M Egger, V Gallo, R Golub, JPT Higgins, ... PeerJ Preprints, 2019 | 107 | 2019 |
| Plasminogen activator inhibitor-1 and type 2 diabetes: a systematic review and meta-analysis of observational studies J Yarmolinsky, N Bordin Barbieri, T Weinmann, PK Ziegelmann, ... Scientific reports 6 (1), 17714, 2016 | 105 | 2016 |
| Effect of tea on blood pressure for secondary prevention of cardiovascular disease: a systematic review and meta-analysis of randomized controlled trials J Yarmolinsky, G Gon, P Edwards Nutrition reviews 73 (4), 236-246, 2015 | 89 | 2015 |
| Association between genetically proxied inhibition of HMG-CoA reductase and epithelial ovarian cancer J Yarmolinsky, CJ Bull, EE Vincent, J Robinson, A Walther, GD Smith, ... Jama 323 (7), 646-655, 2020 | 88 | 2020 |
| Appraising the role of previously reported risk factors in epithelial ovarian cancer risk: a Mendelian randomization analysis J Yarmolinsky, CL Relton, A Lophatananon, K Muir, U Menon, ... PLoS medicine 16 (8), e1002893, 2019 | 68 | 2019 |
| MR-Base: a platform for systematic causal inference across the phenome using billions of genetic associations G Hemani, J Zheng, KH Wade, C Laurin, B Elsworth, S Burgess, ... eLife Sciences Publications, Ltd, 2018 | 60 | 2018 |
| Circulating inflammatory cytokines and risk of five cancers: a Mendelian randomization analysis E Bouras, V Karhunen, D Gill, J Huang, PC Haycock, MJ Gunter, ... BMC medicine 20, 1-15, 2022 | 51 | 2022 |
| Coffee consumption, newly diagnosed diabetes, and other alterations in glucose homeostasis: a cross-sectional analysis of the longitudinal study of adult health (ELSA-Brasil) J Yarmolinsky, NT Mueller, BB Duncan, MC Bisi Molina, AC Goulart, ... PLoS One 10 (5), e0126469, 2015 | 51 | 2015 |
| Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis J Yarmolinsky, V Díez-Obrero, TG Richardson, M Pigeyre, J Sjaarda, ... PLoS medicine 19 (2), e1003897, 2022 | 36 | 2022 |
| Identifying molecular mediators of the relationship between body mass index and endometrial cancer risk: a Mendelian randomization analysis E Hazelwood, E Sanderson, VY Tan, KS Ruth, TM Frayling, N Dimou, ... BMC medicine 20 (1), 125, 2022 | 34 | 2022 |
| Genetic and observational evidence supports a causal role of sex hormones on the development of asthma R Arathimos, R Granell, P Haycock, RC Richmond, J Yarmolinsky, ... Thorax 74 (7), 633-642, 2019 | 33 | 2019 |
| Artificially sweetened beverage consumption is positively associated with newly diagnosed diabetes in normal-weight but not in overweight or obese Brazilian adults J Yarmolinsky, BB Duncan, LE Chambless, IM Bensenor, SM Barreto, ... The Journal of nutrition 146 (2), 290-297, 2016 | 29 | 2016 |
| Statins as potential chemoprevention or therapeutic agents in cancer: a model for evaluating repurposed drugs N Joharatnam-Hogan, L Alexandre, J Yarmolinsky, B Lake, N Capps, ... Current Oncology Reports 23, 1-13, 2021 | 28 | 2021 |
| Investigating the transparency of reporting in two-sample summary data Mendelian randomization studies using the MR-Base platform B Woolf, N Di Cara, C Moreno-Stokoe, V Skrivankova, K Drax, ... International Journal of Epidemiology 51 (6), 1943-1956, 2022 | 25 | 2022 |
| Mendelian randomisation analysis of circulating adipokines and C‐reactive protein on breast cancer risk T Robinson, RM Martin, J Yarmolinsky International journal of cancer 147 (6), 1597-1603, 2020 | 25 | 2020 |
